Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34M Buy
6,602
+150
+2% +$39.9K 0.05% 351
2026
Q1
$976K Buy
6,452
+300
+5% +$36.4K 0.02% 517
2025
Q4
$672K Buy
6,152
+1,000
+19% +$145K 0.02% 588
2025
Q3
$729K Buy
5,152
+262
+5% +$38.2K 0.02% 560
2025
Q2
$791K Buy
4,890
+1,855
+61% +$230K 0.02% 591
2025
Q1
$324K Buy
3,035
+328
+12% +$45.7K 0.01% 753
2024
Q4
$334K Buy
+2,707
New +$382K 0.01% 678

Other funds holding ARM

Geneos Wealth Management's ARM Position: Q2 2026 in Review

Geneos Wealth Management increased its Arm (ARM) stake by 2.3% in Q2 2026, buying an estimated $39.9K and bringing the position to 6,602 shares worth $2.34M. The position accounts for 0.05% of the portfolio, ranked #351.

Geneos Wealth Management first reported a position in ARM in Q4 2024 and has held it in 7 quarters since. 961 funds tracked by Wall St. Rank hold ARM as of Q2 2026.

  • Geneos Wealth Management held 6,602 shares of Arm worth $2.34M as of Q2 2026.
  • Geneos Wealth Management bought 150 Arm shares in Q2 2026, an estimated $39.9K.
  • Arm made up 0.05% of Geneos Wealth Management's portfolio in Q2 2026, its #351 holding.
  • Geneos Wealth Management first reported a position in Arm in Q4 2024 and has held it in 7 quarters since.
  • 961 funds tracked by Wall St. Rank held Arm as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.